TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Unimedic Pharma Holding AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 359 | 364 | 282 |
Financial expenses | 153 | 131 | 141 |
Earnings before taxes | -282 | -178 | -155 |
EBITDA | -140 | -51 | -16 |
Total assets | 7,301 | 7,449 | 7,530 |
Current assets | 281 | 114 | 112 |
Current liabilities | 682 | 1,219 | 645 |
Equity capital | 29 | 49 | 86 |
- share capital | 27 | 29 | 30 |
Employees (average) | 0 | 0 | 3 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 0.4% | 0.7% | 1.1% |
Turnover per employee | 94 | ||
Profit as a percentage of turnover | -78.6% | -48.9% | -55.0% |
Return on assets (ROA) | -1.8% | -0.6% | -0.2% |
Current ratio | 41.2% | 9.4% | 17.4% |
Return on equity (ROE) | -972.4% | -363.3% | -180.2% |
Change turnover | 25 | 87 | 232 |
Change turnover % | 7% | 31% | 466% |
Chg. No. of employees | 0 | -3 | 3 |
Chg. No. of employees % | -100% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.